OxUSC has implemented the statistical analysis for several clinical studies conducted by a company that has developed and is testing a novel in vitro leucocyte blood test device across a range of sectors (cross-over trials, data with biological and technical replicates). The analyses included trials with Sepsis patients, COVID-19 patients, and healthy control groups, as well as a study on healthy participants assessing the link between leucocyte readings and stress. Findings from the descriptive and multivariable and mixed-effects regression analyses are feeding into academic journal publications and providing insights into the further development of the test device.